Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [¸ÞµðÆÄ³ª´º½º] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ±¹°¡¹é½Å ¼ö±Þ ¸ð´ÏÅ͸µ »ç¾÷ Âü¿©
³»   ¿ë
[¸ÞµðÆÄ³ª´º½º = ÀÌÈ£¿µ ±âÀÚ] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò´Â Áúº´°ü¸®º»ºÎ°¡ Áö³­´Þ ¹ßÁÖÇÑ ¹Î°£À§Å¹»ç¾÷ÀÎ '2020³âµµ ±¹°¡¹é½Å ¼ö±Þ ¸ð´ÏÅ͸µ ¹× ¼ö¿ä ¿¹Ãø ¸ðµ¨¸µ' »ç¾÷¿¡ Âü¿©ÇÑ´Ù.
 
À̹ø ¿¬±¸»ç¾÷Àº ¿¹¹æÁ¢Á¾ ¹é½Å ¼ö±ÞÇöȲ ºÐ¼® ¹× Àü¸ÁÀ» ÅëÇÑ ¹é½Å ¼ö±ÞÀÇ ¾ÈÁ¤È­ µµ¸ð, ¼ö±Þ ºÒ¾È Á¶±â°æº¸Ã¼°è °­È­ ¹× ±¹³»¿Ü ¹é½Å »ê¾÷ ½ÃÀå ºÐ¼® µî °ü·Ã ¾÷¹« Áö¿øÃ¼°è ±¸Ãà µîÀ» ¸ñÇ¥·Î ÃßÁøµÆ´Ù.
 
¼º±Õ°ü´ë ÀÌ»ó¿ø ±³¼öÆÀÀÌ ÃѰý ¹× ¼¼ºÎ°úÁ¦ 1À» ¸Ã°í, Çѱ¹Á¦¾à¹ÙÀÌ¿ÀÇùȸ¿Í ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò°¡ °¢°¢ ¼¼ºÎ°úÁ¦ 2 ¹× ¼¼ºÎ°úÁ¦ 3À» ¸Ã¾Æ ¿Ã ¿¬¸»±îÁö ÁøÇàÇÏ°Ô µÈ´Ù.
 
ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò°¡ ¸Ã¾Æ ÁøÇàÇÏ´Â ¼¼ºÎ°úÁ¦ 3Àº ÀÓÀ翵 ¿¬±¸Á¶Á¤½ÇÀåÀÇ Ã¥ÀÓ ÇÏ¿¡ ±¹°¡¹é½Å ¼ö±Þ Àü¸Á ¿¹Ãø ¹× ¿¹Ãø¸ðµ¨ °íµµÈ­¸¦ ÁÖÁ¦·Î ¼öÇàµÈ´Ù.
 
±¹°¡¹é½Å ¼ö±Þ Àü¸Á ¿¹ÃøÀº 22Á¾ ±¹°¡¹é½ÅÀÇ »ý»ê¡¤°ø±Þ¡¤»ç¿ë·®ÀÇ ÇöȲ ºÐ¼®À» ¹ÙÅÁÀ¸·Î ÀÌ·ïÁö¸ç, ÀÌ Áß ¿¹Ãø¸ðµ¨ °íµµÈ­´Â °í·Á´ëÇб³ ½ÄǰÀÚ¿ø°æÁ¦ÇаúÀÇ ¹ÚÈ£Á¤ ±³¼ö°¡ Âü¿©ÇØ »çȸ³×Æ®¿öÅ©¸ðµ¨ ¿¬°è ¹× È®ÀåÇü Áúº´È®»ê¸ðÇüÀ» °³¹ßÇÏ°í ¹é½ÅÀÇ ÃÖÀû°ø±Þ±Ô¸ð¸¦ »êÃâÇÒ °èȹÀÌ´Ù.
 
¿¬±¸¼Ò´Â À̹ø ¿¬±¸»ç¾÷ ÃßÁøÀÇ ±â´ëÈ¿°ú·Î ¡âÇâÈÄ ¹é½Å ¼ö±Þ Àü¸ÁÀ» ¿¹ÃøÇÔÀ¸·Î½á ¹é½Å °ø±ÞÀÇ ½Å¼Ó¼º ¹× ¾ÈÁ¤¼º È®º¸ ¡âÁúº´È®»êÀÇ µ¿ÅÂÀû ¼º°ÝÀ» ¹Ý¿µÇÑ °æÁ¦-¿ªÇÐ ¸ðÇüÀÇ ±¸ÃàÀ» ÅëÇØ ¹é½Å °ø±Þ¿¡ ¼Ò¿äµÇ´Â »çȸÀû ºñ¿ë ÃÖ¼ÒÈ­ ¡â¹é½Å ºÎÁ· »óȲ¿¡ ¼±Á¦ÀûÀ¸·Î ´ëÀÀÇÔÀ¸·Î½á Áß´Ü ¾ø´Â ¿¹¹æÁ¢Á¾¿¡ ±â¿© µîÀ» µé¾ú´Ù.
 
¶ÇÇÑ ¿¬±¸¼º°ú°¡ ÇâÈÄ ±¹°¡¿¹¹æ Á¢Á¾ Á¤Ã¥ÀÇ ±âÃÊÀÚ·á·Îµµ Ȱ¿ëµÉ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ë°¨À» ³ªÅ¸³Â´Ù.


[±â»ç Ãâó]http://medipana.com/news/news_viewer.asp?NewsNum=257117&MainKind=A&NewsKind=5&vCount=12&vKind=1




 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
39 [¸Þµð°ÔÀÌÆ®] "Äڷγª19 À¯Çà ³¡³ªµµ ¹é½Å ¿¬±¸°³¹ß °è¼Ó..3000¸¸¸íºÐ ±¹°¡ ºñÃà" ±è¼±Èñ 2020-05-29 1103
38 [¾à¾÷½Å¹®] ¡°Äڷγª19 Ä¡·áÁ¦¡¤¹é½Å, °æÀïÁ¦Ç° ºñ±³¿ìÀ§ È®º¸ Çʼö¡± ±è¼±Èñ 2020-05-29 1141
37 [¾à¾÷½Å¹®] Äڷγª19 ¹é½Å º¸À¯·® Àü ±¹¹Î 52~62% ¼öÁØ µÅ¾ß ±è¼±Èñ 2020-05-29 931
36 [ÄíŰ´º½º] ¡°Äڷγª19 ¹é½Å °³¹ß¡¤ºñÃà, Á¤ºÎ °³ÀÔ ÇʼöÀû¡± ±è¼±Èñ 2020-05-29 801
35 [Àϰ£º¸»ç] ¡®Äڷγª19, Àü ±¹¹Î 60% Á¢Á¾ÇÒ ¹é½Åȯ°æ ±¸ÃàµÅ¾ß¡¯ ±è¼±Èñ 2020-05-29 676
34 [µ¥Àϸ®ÆÊ]"±¹¹Î 60%°¡ ¹é½Å ¸Â¾Æ¾ß Äڷγª19 À¯Çà ¸·´Â´Ù" ±è¼±Èñ 2020-05-29 715
33 [¾à»ç°ø·Ð] ÀǾàǰÁ¤Ã¥¿¬, ¡®Äڷγª19 Ä¡·áÁ¦ ¹× ¹é½Å°³¹ß¡¯ ÁÖÁ¦ Æ÷·³ °³ÃÖ ±è¼±Èñ 2020-05-29 693
32 [´ëÇѾà»çÀú³Î]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®_°í·ÉÈ­¡¤¸¸¼ºÁúȯÀ¸·Î ÀÎÇÑ ÀǾàǰ ¼Òºñ º¯È­ 2 ±è¼±Èñ 2020-05-25 782
31 [´ëÇѾà»çÀú³Î] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®_2019³â OECD ÇÑ´«¿¡ º¸´Â °Ç°­(Health at a Glance) 1 ±è¼±Èñ 2020-05-25 880
30 [µ¥Àϸ®ÆÊ] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, Áúº» ¹ßÁÖ ±¹°¡¹é½Å ¿¬±¸ Âü¿© ±è¼±Èñ 2020-05-21 996
29 [º¸°Ç´º½º] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¡®±¹°¡¹é½Å ¼ö±Þ ¸ð´ÏÅ͸µ ¹× ¼ö¿ä ¿¹Ãø ¸ðµ¨¸µ¡¯ »ç¾÷ Âü¿© ±è¼±Èñ 2020-05-21 844
28 [¸ÞµðÆÄ³ª´º½º] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ±¹°¡¹é½Å ¼ö±Þ ¸ð´ÏÅ͸µ »ç¾÷ Âü¿© ±è¼±Èñ 2020-05-21 703
27 [Àϰ£º¸»ç] ¿ì¸®³ª¶ó ÀǾàǰ ¼Òºñ Áõ°¡À² ¡®ÃÖ»óÀ§¡¯ ±è¼±Èñ 2020-05-15 971
26 [µ¥Àϸ®ÆÊ] Àα¸ 10¸¸¸í´ç ¾à±¹¼ö, OECD Æò±Õº¸´Ù 1.4¹è ³ô¾Æ ±è¼±Èñ 2020-05-15 1199
25 [¸Þµð°ÔÀÌÆ®]¾à±¹ 1ÀÎ °æ¿µ ¹æ½Ä À§ÁÖ.."OECD ´ëºñ ¾à±¹ ¼ö´Â ¸¹Áö¸¸ ¾à»ç´Â Æò±Õ ÀÌÇÏ" ±è¼±Èñ 2020-05-15 791

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»